All In Biotech

Free tool

FAERS Monitor: Epipen E Z Pen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019430 or its brand name (Epipen E Z Pen, Epinephrine). Reports on generic versions are filed under their own applications.

Reports

65,115

Serious

37,014

57% of reports

Hospitalization

17,948

Death reported

4,036

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5,929
  • headache4,422
  • fatigue4,074
  • sinusitis4,052
  • dyspnoea3,477
  • nausea3,396
  • pain3,365
  • product dose omission issue3,247
  • off label use2,904
  • pneumonia2,668
  • covid-192,631
  • cough2,285
  • pyrexia2,232
  • nasopharyngitis2,208
  • pruritus2,186

Reports by year received

View as table
YearReports
2004160
2005146
2006167
2007233
2008352
2009360
2010536
20111,018
2012819
2013713
20141,430
20152,554
20166,749
20173,571
20183,419
20194,195
20207,414
20214,941
20224,661
20234,945
20245,804
20256,158
20264,767

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,989,044 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal4,05213.312.944,302
covid-19Signal2,6314.94.78,114
nasopharyngitisSignal2,2083.93.74,751
product dose omission issueSignal3,2473.63.56,099
pneumoniaSignal2,6682.72.62,818
coughSignal2,2852.62.52,349
headacheSignal4,4222.32.23,278
pyrexiaSignal2,2322.12.01,282
dyspnoea3,4772.01.91,748
pruritus2,1861.81.8852
pain3,3651.81.71,163
fatigue4,0741.71.61,196
drug ineffective5,9291.51.4896
nausea3,3961.41.3380
off label use2,9041.11.014

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.